Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
America Great Health has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution activity is limited to 1 distinct examiner and a distinct art unit. This suggests that the company's current patenting activity is focused on a specific technological development within the pharmaceutical field. By concentrating on a single art unit, the applicant can more effectively manage the technical requirements and expectations of the patent office. This focused approach is beneficial for navigating the complex Biotechnology & Pharmaceuticals landscape.
CHANDRA, GYAN is the busiest examiner, currently managing 1 pending office action. This single action represents the total pending workload for the portfolio. Because there is 1 pending office action, the applicant's primary focus is on the requirements and feedback provided by this one examiner. The concentration in a single art unit indicates a specialized prosecution path. With 1 pending office action assigned to CHANDRA, GYAN, the company can dedicate its full attention to resolving this specific matter. This simplified structure reduces administrative overhead and allows for a more direct engagement with the patent examination process.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| No statute on record | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHANDRA, GYAN | 1 | 71.3% | +27.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17849626 | Formulation and Method of Preparing Divalent Cation Charged Insulin for Oral Administration | CHANDRA, GYAN | 27d |
| Art Unit | Apps |
|---|---|
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17849626 | Formulation and Method of Preparing Divalent Cation Charged Insulin for Oral Administration | CHANDRA, GYAN | 1674 | Other | Final Rejection | 27d | Pending | Jun 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial